High-Throughput Screening (HTS) Market

The report "High-Throughput Screening (HTS) Market by Instruments (Liquid Handling, Detection, Imaging), Consumables (Reagents, Kits), Software, Services, Technology (Cell-based, High-content, Label-free), Workflow, Application, Competition - Global Forecast to 2031" The high-throughput screening (HTS) market is expected to reach USD 45.90 billion by 2031 from USD 27.66 billion in 2026, at a CAGR of 10.7% during the forecast period.

Browse 735 market data Tables and 60 Figures spread through 600 Pages and in-depth TOC on "High-Throughput Screening (HTS) Market by Instruments (Liquid Handling, Detection, Imaging), Consumables (Reagents, Kits), Software, Services, Technology (Cell-based, High-content, Label-free), Workflow, Application, Competition - Global Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/high-throughput-screening-market-134981950.html

The high-throughput screening (HTS) market is experiencing steady growth, driven by rising R&D spending by pharmaceutical and biotechnology companies, the adoption of open innovation models, and government funding and venture capital investments in drug discovery. The need to screen large compound and biological libraries faster and with higher accuracy is encouraging wider adoption of automated screening platforms, assay kits, microplate-based workflows, and advanced informatics tools. Technological advancements in high-content screening, cell-based assays, label-free detection, 3D cell culture models, organoids, and AI-enabled data analysis are also improving screening efficiency and hit quality. Additionally, the growing use of outsourced HTS services by biotech firms, academic institutions, and pharmaceutical companies is expected to further support market growth in the coming years.

By service type, the primary screening services segment accounted for the largest share of the high-throughput screening (HTS) market in 2025.

By service type, the high-throughput screening (HTS) market is divided into assay development & optimization services, compound library management services, primary screening services, secondary screening & hit confirmation services, hit validation & characterization services, data analysis & informatics services, and other services. In 2025, primary screening services held the largest share of the high-throughput screening (HTS) services market, as they form the core outsourced activity in early-stage drug discovery. These services are widely used by pharmaceutical and biotechnology companies to rapidly and cost-effectively screen large compound, gene, or cell libraries using automated platforms, microplate-based assays, and advanced detection systems.

By end user, the CROs & CDMOs segment is estimated to register the fastest growth in the global high-throughput screening (HTS) products market during the forecast period of 2026–2031.

Based on end users, the high-throughput screening (HTS) products market is divided into pharmaceutical & biotechnology companies, CROs & CDMOs, academic & research institutes, and other end users. During the forecast period, CROs & CDMOs are expected to grow at the fastest growth rate, supported by the rising outsourcing of early-stage drug discovery, assay development, screening, and hit identification activities. Many emerging biotechnology firms and mid-sized pharmaceutical companies prefer outsourcing HTS workflows to reduce capital expenditure and access specialized automation, compound libraries, assay platforms, and data analysis capabilities. This trend is increasing product demand among CROs, including microplate readers, liquid handling systems, assay kits, reagents, consumables, and screening software.

North America accounted for the largest share of the high-throughput screening (HTS) market in 2025.

The high-throughput screening (HTS) market is divided into North America, Europe, Asia Pacific (APAC), Latin America (LATAM), the Middle East, and Africa. In 2025, North America held the largest share of the global high-throughput screening (HTS) market, supported by strong pharmaceutical and biotechnology R&D activity, advanced laboratory infrastructure, and the presence of leading life science tools companies and CROs. The US remains the major contributor due to its large base of drug discovery companies, academic research centers, government-funded laboratories, and contract research organizations. High adoption of automated liquid handling systems, microplate readers, high-content screening platforms, label-free technologies, and AI-enabled data analysis tools further strengthens the region’s leadership in the HTS market.

Key players in the high-throughput screening (HTS) market include Thermo Fisher Scientific Inc. (US), Agilent Technologies, Inc. (US), Merck KGaA (Germany), Danaher Corporation (US), Revvity, Inc. (US), Tecan Group Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (US), and Corning Incorporated (US), among others.

Don’t miss out on business opportunities in High-Throughput Screening (HTS) Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]